Back
ProShares Ultra Nasdaq Biotechnology Stock Price Chart
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
30
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
$39.71
Seasonality Move:
12.2%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing selling pressure, which indicates risk of future bearish movement.
ProShares Ultra Nasdaq Biotechnology Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.99 | Sell |
| 20-day SMA: | 43.49 | Sell |
| 50-day SMA: | 47.34 | Sell |
| 200-day SMA: | 56.79 | Sell |
| 8-day EMA: | 42.71 | Sell |
| 20-day EMA: | 43.86 | Sell |
| 50-day EMA: | 46.61 | Sell |
| 200-day EMA: | 53.33 | Sell |
ProShares Ultra Nasdaq Biotechnology Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.16 | Sell |
| Relative Strength Index (14 RSI): | 37.67 | Sell |
| Chaikin Money Flow: | -12266 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.59 - 45.61) | Sell |
| Bollinger Bands (100): | (45.23 - 55.87) | Sell |
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ProShares Ultra Nasdaq Biotechnology Stock
Is ProShares Ultra Nasdaq Biotechnology Stock a Buy?
-
ProShares Ultra Nasdaq Biotechnology share price is 39.63 while BIB 8-day simple moving average is 43.99, which is a Sell signal.
-
The stock price of BIB is 39.63 while ProShares Ultra Nasdaq Biotechnology 20-day SMA is 43.49, which makes it a Sell.
-
ProShares Ultra Nasdaq Biotechnology 50-day simple moving average is 47.34 while BIB share price is 39.63, making it a Sell technically.
-
BIB stock price is 39.63 and ProShares Ultra Nasdaq Biotechnology 200-day simple moving average is 56.79, creating a Sell signal.
BIB Technical Analysis vs Fundamental Analysis
Sell
30
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy or a Sell?
-
ProShares Ultra Nasdaq Biotechnology stock is rated a SellThe current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $39.63. The Score for BIB is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
ProShares Ultra Nasdaq Biotechnology Stock Info
Market Cap:
0
Price in USD:
39.63
Share Volume:
12.3K
ProShares Ultra Nasdaq Biotechnology 52-Week Range
52-Week High:
69.56
52-Week Low:
33.78
Sell
30
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
ProShares Ultra Nasdaq Biotechnology Share Price Forecast
-
What is the ProShares Ultra Nasdaq Biotechnology stock price today?The ProShares Ultra Nasdaq Biotechnology stock price is 39.63 USD today.
-
Will BIB stock go up or go down?ProShares Ultra Nasdaq Biotechnology> share price is forecast to RISE/FALL based on technical indicators
-
Is ProShares Ultra Nasdaq Biotechnology overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProShares Ultra Nasdaq Biotechnology is overvalued.
Is ProShares Ultra Nasdaq Biotechnology Stock a Buy?
-
ProShares Ultra Nasdaq Biotechnology share price is 39.63 while BIB 8-day exponential moving average is 42.71, which is a Sell signal.
-
The stock price of BIB is 39.63 while ProShares Ultra Nasdaq Biotechnology 20-day EMA is 43.86, which makes it a Sell.
-
ProShares Ultra Nasdaq Biotechnology 50-day exponential moving average is 46.61 while BIB share price is 39.63, making it a Sell technically.
-
BIB stock price is 39.63 and ProShares Ultra Nasdaq Biotechnology 200-day simple moving average is 53.33, creating a Sell signal.
Technical Analysis of ProShares Ultra Nasdaq Biotechnology
Should I short ProShares Ultra Nasdaq Biotechnology stock?
-
BIB Moving Average Covergence Divergence (MACD) indicator is -1.16, suggesting ProShares Ultra Nasdaq Biotechnology is a Sell
-
ProShares Ultra Nasdaq Biotechnology Relative Strength Index (RSI) is 37.67, which suggest ProShares Ultra Nasdaq Biotechnology is oversold
-
The Bollinger Bands (25) for ProShares Ultra Nasdaq Biotechnology is (39.59 - 45.61), which suggest ProShares Ultra Nasdaq Biotechnology is a Sell
-
The Bollinger Bands (100) for ProShares Ultra Nasdaq Biotechnology is (45.23 - 55.87), which suggest ProShares Ultra Nasdaq Biotechnology is a Sell
* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.